Newark, NJ -- (SBWIRE) -- 04/18/2013 -- stockmarketprofessor.com brings Stock market news, stock quotes, stock charts, stock research and hot penny stock picks. Investors can utilize STOCKMARKETPROFESSOR.COM services to research a variety of small cap and penny stocks.Have a look on Today’s Picks: Acura Pharmaceuticals (NASDAQ:ACUR), Alkermes(NASDAQ:ALKS), Delcath Systems (NASDAQ:DCTH)
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) soared on news the FDA has banned old OxyContin generics from coming to the market. U.S. regulators said that generic-drug companies will not be allowed to make copies of older versions of OxyContin that don’t have tamper-resistant qualities. The Food and Drug Administration recently found that closely held Purdue Pharma LP, maker of a reformulated OxyContin, pulled old versions of the popular painkiller without abuse-deterrent measures from the market for safety or effectiveness reasons.
Will ACUR Continue To Move Higher? Find Out Here
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) gained +33.95% to close at $2.88 and its overall volume in the last trading session was 13.01 million shares, beating the average volume of 523,153. ACUR hit the day high price of $3.78 and day low of $2.73.
The stock is trading with positive year-to-date performance of +9.73%. It has current ratio of 19.73. The company has total market cap of $133.57 million.
AlkermesPlc (NASDAQ:ALKS) scored new high after saying that its treatment for major depressive disorder showed considerably lower symptoms across a number of measures in hard-to-treat patients, according to preliminary data from a Phase 2 study. The biopharmaceutical company, on the basis of recent and previous trial results, disclosed plan to request a meeting with the FDA and to advance the treatment into a development program.
For How Long ALKS will Fight for Profitability? Read This Trend Analysis report
AlkermesPlc (NASDAQ:ALKS) jumped +16.09% with the closing price of $29.72. The overall volume in the last trading session was 7.28 million shares. Its fifty two week range was $14.82-$30.29. The total market capitalization remained $3.96 billion.
The stock is ahead its 52 week low with 100.54% and its last month price volatility remained 3.26%. Its beta coefficient was 0.83 with a target price of $25.45. In its share capital, the company has 133.17 million outstanding shares while 124.48 million shares have been floated in market.
It has insider ownership of 0.65% with its institutional ownership remained 91.24%. Its current year earnings per share dropped with -108.07% while the five year EPS growth rate was +288.73%.
Delcath Systems, Inc. (NASDAQ:DCTH) shares went -4.11% down and closed at $1.40 in the last trading session. Its overall traded volume was 2.91 million shares. The stock’s opening price was $1.44, hitting the day high price of $1.47 and day low of $1.31.
DCTH has earnings per share of -$0.93. The company has -157.86% returns on assets, -224.96% returns on equity and its return on investments is -222.03%.
Has DCTH Found The Bottom and Ready To Move Up? Find Out Here
stockmarketprofessor.com brings Stock market news, stock quotes, stock charts, stock research and hot penny stock picks. Investors can utilize STOCKMARKETPROFESSOR.COM services to research a variety of small cap and penny stocks. stockmarketprofessor.com collect information from you when you register on our site, place an order or subscribe to our newsletter.
Please Read carefully before buying any stock. stockmarketprofessor.com has a no tolerance spam policy, we will not sell or re distributes your email to any third party.
If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members. Verify all claims and do your own due diligence. stockmarketprofessor.com profiles are not a solicitation or recommendation to buy, sell or hold securities. stockmarketprofessor.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. stockmarketprofessor.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies.
Read full disclaimer at: http://www.stockmarketprofessor.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)